drugset / Trial / NCT02852720

Pharmacokinetics of Levobupivacaine After Cesarean Section

NCT02852720

Phase 4 Completed 12 enrolled Pontificia Universidad Catolica de Chile
NaSingle-groupOpen-labelBasic science

Summary

Transversus abdominis plane (TAP) block provides effective analgesia and is now a standard of care for analgesia after cesarean section. There is no information on levobupivacaine pharmacokinetics post TAP after pregnancy. Objective: Generate a pharmacokinetic levobupivacaine model and its effect on the electrocardiogram (ECG). Method: The investigators will study 12 healthy term pregnant patients, scheduled for elective cesarean section under spinal anesthesia. A bilateral TAP block is performed with 20 ml 0.25% levobupivacaine with epinephrine 5 ug/ml. Sensory block will be assessed at 1-2-6 and 12 hours post puncture. 2 ml of venous blood will be obtained at 2-5-10-30-45-60-90 and 180 minutes. With a Holter machine we will study the effect of levobupivacaine plasma levels and the QTc changes. Expected results: 1) Plasma levobupivacaine levels; 2) Changes in QTc .

Timeline

Start
2016-12-15
Primary completion
2017-02-15
Completion
2017-02-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 0.25 % Other

Indications